Skip to content
InsideEdge
Investors / filer profile

No completed buy history yet — outcomes appear once a disclosed buy is ~6 months old.

Disclosed positions

Estimated from their latest filings — positions may have changed since

$28.31M
combined est. value

Activity

Open-market buy & sell volume

BuySell
0$66.2M$132.5M2025 · bought $0 · sold $132.5M20252026 · bought $864K · sold $84.3M2026
Total +$863.9K bought · $216.74M sold
Most bought

All filings on record

Every Form 4 transaction we track for this filer

UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$66.7K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$354.7K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$443.2K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$910.3K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$1.58M
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$798.8K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$843.3K
UTHRSell
2026-07-09 · UNITED THERAPEUTICS Corp
$241.2K
UTHRExercise
2026-07-09 · UNITED THERAPEUTICS Corp
$1.29M
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$179.5K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$122.9K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$391.6K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$211.0K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$161.7K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$619.9K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$946.4K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$823.2K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$510.2K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$432.1K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$507.2K
UTHRSell
2026-07-08 · UNITED THERAPEUTICS Corp
$349.5K
UTHRExercise
2026-07-08 · UNITED THERAPEUTICS Corp
$1.29M
UTHRSell
2026-07-07 · UNITED THERAPEUTICS Corp
$34.9K
UTHRSell
2026-07-07 · UNITED THERAPEUTICS Corp
$450.1K
UTHRSell
2026-07-07 · UNITED THERAPEUTICS Corp
$283.0K

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.